# Elderly individuals exhibit dysregulated monocyte responses to viral immune complexes compared to adults and children

**Authors:** Léa Domitien Payet, Anthony Coléon, Anne Sophie Bedin, Lucas Auguste, Maël Morvan Duroyon, Caroline Mollevi, Hubert Blain, Franck Mennechet, Éric Jeziorski, Édouard Tuaillon

PMC · DOI: 10.1038/s41598-025-13883-7 · Scientific Reports · 2025-08-01

## TL;DR

Elderly people have weaker and less controlled immune responses to virus-related immune complexes compared to adults and children, which could explain why they are more vulnerable to certain viral infections.

## Contribution

The study reveals age-related differences in monocyte activation and cytokine responses to viral immune complexes, linking these differences to immunosenescence and chronic inflammation in the elderly.

## Key findings

- Elderly monocytes show weak activation and reduced cytokine responses to immune complexes compared to adults and children.
- Children exhibit moderate immune responses, potentially influenced by trained immunity from early-life pathogen exposure.
- Elderly individuals have high baseline cytokine levels even without stimulation, indicating chronic inflammation.

## Abstract

The severity of certain viral infectious diseases varies across the age; we hypothesize that these variations could be related to the variation of immune responses to viral immune complexes (ICs) among the age. This study aimed to investigate monocyte activation in response to ICs in children, adults, and elderly individuals. An experimental in vitro model was established using peripheral blood mononuclear cells from healthy individuals. Monocyte activation markers (CD169, CD38, HLA-DR), the negative co-stimulatory molecule (PD-L1), and cytokine production were measured under basal conditions and upon stimulation with human adenovirus 5-IgG immune complex (Ad5-ICs), interferon-alpha (IFN-α), and lipopolysaccharide (LPS). Monocytes from children and adults displayed similar activation profiles in response to ICs and IFN-α stimulation, characterized by increased expression of CD169 and PD-L1. In contrast, monocytes from elderly individuals exhibited weak or no overexpression of CD169 and PD-L1 coupled with a diminished PBMC cytokine response. Notably, cells from elderly participants produced high levels of TNF-α, IL-1α, and IL-6 in the absence of stimulation. Multiple comparisons confirmed reduced monocyte activation and PBMC cytokine responses in the elderly compared to adults and children. Although children exhibited a significant response to ICs, their secretion of IFN-α, IP-10, IFN-γ, IL-8, and IL-2 was lower than that observed in adults. Our findings suggest that elderly individuals have poor and dysregulated responses to ICs, likely due to immunosenescence and chronic inflammation. Adults exhibit a robust and balanced response to ICs, while children display a moderate response, possibly influenced by ‘trained immunity’ resulting from frequent early-life exposures to pathogens. These insights highlight the importance of further research to develop age-specific therapeutic strategies to modulate immune function during viral IC exposure.

## Linked entities

- **Proteins:** SIGLEC1 (sialic acid binding Ig like lectin 1), CD38 (CD38 molecule), CD274 (CD274 molecule), TNF (tumor necrosis factor), IL1A (interleukin 1 alpha), IL6 (interleukin 6), IFN1@ (interferon, type 1, cluster), CXCL10 (C-X-C motif chemokine ligand 10), IFNG (interferon gamma), CXCL8 (C-X-C motif chemokine ligand 8), IL2 (interleukin 2)

## Full-text entities

- **Genes:** IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SIGLEC1 (sialic acid binding Ig like lectin 1) [NCBI Gene 6614] {aka CD169, SIGLEC-1, SN}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** chronic inflammation (MESH:D007249), infectious diseases (MESH:D003141)
- **Chemicals:** LPS (MESH:D008070)
- **Species:** Adenoviridae (family) [taxon 10508], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316873/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12316873/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12316873/full.md

---
Source: https://tomesphere.com/paper/PMC12316873